SCHEMBL9147472

SCHEMBL9147472

CN(Cc1ccc(C#N)cc1)C1CCC(=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.47
DPP9 Q86TI2 1/20 0.47
DPP7 Q9UHL4 1/20 0.47
HRH3 Q9Y5N1 2/20 0.46
HRH4 Q9H3N8 1/20 0.46
SLC6A4 P31645 3/20 0.45
SLC6A2 P23975 2/20 0.45
NSD2 O96028 2/20 0.43
NAAA Q02083 1/20 0.41
GRIN2B Q13224 1/20 0.41
PARP1 P09874 1/20 0.41
CYP2A6 P11509 1/20 0.40
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25087719 0.83 HRH3 (0.68) DPP4DPP9DPP7HRH3HRH4
SCHEMBL7321429 0.80 HRH3 (0.50) HRH3HRH4SLC6A4SLC6A2GRIN2B
SCHEMBL785128 0.80 GRIN2B (0.60) HRH3HRH4NAAAGRIN2B
SCHEMBL14136358 0.72 DPP4 (0.43) DPP4DPP9DPP7HRH3HRH4
SCHEMBL9451632 0.72 KDM4E (0.57) DPP4DPP9DPP7NSD2
SCHEMBL467367 0.71 MCHR1 (0.47) SLC6A4NAAAGRIN2BNOS3NOS1
SCHEMBL9457804 0.71 MAOA (0.56) HRH3CYP2A6GAA
SCHEMBL14183554 0.71 KCNJ1 (0.50)
Hydrochloric Acid SCHEMBL7339715 0.70 MCHR1 (0.47) SLC6A4NAAAGRIN2BNOS3NOS1
SCHEMBL156261 0.69 CYP2A6 (0.58) HRH3SLC6A4SLC6A2NSD2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995014469-A1 NOVEL SPIROCYCLES MERCK & CO., INC. (US) 1995-06-01 WO disclosed
US-5403846-A Antiarrhythmic agents MERCK & CO., INC. (US) 1995-04-04 US disclosed